Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nelson B Rodrigues

Showing results (41-50 of 70) with videos related to

Pageof 7
Sort By:
Psychiatry Research|May 25, 2021
The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)Roger S McIntyre, Joshua D Rosenblat, Nelson B Rodrigues, et al.
CNS Spectrums|December 10, 2020
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulationNelson B Rodrigues, Ashley Siegel, Orly Lipsitz, et al.
CNS Spectrums|January 19, 2021
The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid DatasetLeanna M W Lui, Yena Lee, Orly Lipsitz, et al.
CNS Drugs|November 18, 2021
Molecular Mechanisms of Psilocybin and Implications for the Treatment of DepressionSusan Ling, Felicia Ceban, Leanna M W Lui, et al.
CNS Spectrums|January 10, 2025
[The mediational role of cognitive function on occupational outcomes in persons with major depressive and bipolar disorder]Jocelyn K Tamura, Dorottya Harangi, Nelson B Rodrigues, et al.
Psychiatry Research|March 8, 2023
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorderKevork Danayan, Noah Chisamore, Nelson B Rodrigues, et al.
Obesity (Silver Spring, Md.)|October 6, 2020
Antidepressant Medications and Weight Change: A Narrative ReviewHartej Gill, Barjot Gill, Sabine El-Halabi, et al.
Brain, Behavior, and Immunity|March 29, 2023
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysisFelicia Ceban, Dana Kulzhabayeva, Nelson B Rodrigues, et al.
Journal of Affective Disorders|July 5, 2021
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic reviewJason Ng, Joshua D Rosenblat, Leanna M W Lui, et al.
Journal of Affective Disorders|June 23, 2021
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.
Pageof 7

Showing results (41-50 of 70) with videos related to

Sort By:
Pageof 7
Psychiatry Research|May 25, 2021
The effect of intravenous ketamine on cognitive functions in adults with treatment-resistant major depressive or bipolar disorders: Results from the Canadian rapid treatment center of excellence (CRTCE)Roger S McIntyre, Joshua D Rosenblat, Nelson B Rodrigues, et al.
CNS Spectrums|December 10, 2020
Effectiveness of intravenous ketamine in mood disorder patients with a history of neurostimulationNelson B Rodrigues, Ashley Siegel, Orly Lipsitz, et al.
CNS Spectrums|January 19, 2021
The influence of prescriber and patient gender on the prescription of benzodiazepines: results from the Florida Medicaid DatasetLeanna M W Lui, Yena Lee, Orly Lipsitz, et al.
CNS Drugs|November 18, 2021
Molecular Mechanisms of Psilocybin and Implications for the Treatment of DepressionSusan Ling, Felicia Ceban, Leanna M W Lui, et al.
CNS Spectrums|January 10, 2025
[The mediational role of cognitive function on occupational outcomes in persons with major depressive and bipolar disorder]Jocelyn K Tamura, Dorottya Harangi, Nelson B Rodrigues, et al.
Psychiatry Research|March 8, 2023
Real world effectiveness of repeated ketamine infusions for treatment-resistant depression with comorbid borderline personality disorderKevork Danayan, Noah Chisamore, Nelson B Rodrigues, et al.
Obesity (Silver Spring, Md.)|October 6, 2020
Antidepressant Medications and Weight Change: A Narrative ReviewHartej Gill, Barjot Gill, Sabine El-Halabi, et al.
Brain, Behavior, and Immunity|March 29, 2023
COVID-19 vaccination for the prevention and treatment of long COVID: A systematic review and meta-analysisFelicia Ceban, Dana Kulzhabayeva, Nelson B Rodrigues, et al.
Journal of Affective Disorders|July 5, 2021
Efficacy of ketamine and esketamine on functional outcomes in treatment-resistant depression: A systematic reviewJason Ng, Joshua D Rosenblat, Leanna M W Lui, et al.
Journal of Affective Disorders|June 23, 2021
Does pre-treatment functioning influence response to intravenous ketamine in adults with treatment-resistant depression?Roger S McIntyre, Orly Lipsitz, Leanna M W Lui, et al.
Pageof 7